SavedAdd your journal

Journals / İstanbul Tıp Fakültesi Dergisi / 2026 / Cilt: 88 Sayı: 1

MEASLES-MUMPS-RUBELLA VACCINATION IN A PAEDIATRIC TRANSPLANT PATIENT USING EVEROLIMUS

EVEROLIMUS KULLANAN BİR PEDİATRİK TRANSPLANT OLGUSUNDA KIZAMIK-KABAKULAK-KIZAMIKÇIK AŞISI UYGULAMASI

Aybüke Kaçır(ISTANBUL MEDIPOL UNIVERSITY, INTERNATIONAL FACULTY OF MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, DEPARTMENT OF PEDIATRICS, SOCIAL PEDIATRICS)0009-0002-3474-5863
Övgü Büke(ISTANBUL MEDIPOL UNIVERSITY, INTERNATIONAL FACULTY OF MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, DEPARTMENT OF PEDIATRICS, SOCIAL PEDIATRICS)0000-0002-3922-2976
Nalan Karabayır(ISTANBUL MEDIPOL UNIVERSITY, INTERNATIONAL FACULTY OF MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, DEPARTMENT OF PEDIATRICS, SOCIAL PEDIATRICS)0000-0002-8003-1952
Mine Başıbüyük(ISTANBUL MEDIPOL UNIVERSITY, INTERNATIONAL FACULTY OF MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, DEPARTMENT OF PEDIATRICS, SOCIAL PEDIATRICS)0000-0002-9159-4961
Demet Deniz Bilgin(ISTANBUL MEDIPOL UNIVERSITY, INTERNATIONAL FACULTY OF MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, DEPARTMENT OF PEDIATRICS, SOCIAL PEDIATRICS)0000-0002-9794-9460
Özlem Öcal(ISTANBUL MEDIPOL UNIVERSITY, INTERNATIONAL FACULTY OF MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, DEPARTMENT OF PEDIATRICS, SOCIAL PEDIATRICS)0000-0002-4210-2430
Pages
80–82
Publication Date
2025-01-31
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This article presents a case of paediatric solid organ transplantation patient who received a measles-mumps-rubella vaccination while receiving immunosuppressive everolimus therapy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:There is limited information regarding the administration of live vaccines to paediatric transplant patients who are at increased risk of infection.
📊
Key Findings & Data:A 7-year-old liver transplant patient who had everolimus therapy was evaluated for Measles-Mumps-Rubella (MMR) vaccination.
💡
Conclusion & Impact:This article presents a case of paediatric solid organ transplantation patient who received a measles-mumps-rubella vaccination while receiving immunosuppressive everolimus therapy.
🔬Design:Olgu Sunumu
📍Scope:Comprehensive Sample
⚙️Variables:Çocuk · aşılama · everolimus

Abstract

There is limited information regarding the administration of live vaccines to paediatric transplant patients who are at increased risk of infection. A 7-year-old liver transplant patient who had everolimus therapy was evaluated for Measles-Mumps-Rubella (MMR) vaccination. After checking the lymphocyte count, immunoglobulin G, and serum everolimus levels, the MMR vaccine was administered. No side effects were observed during follow-up, and the antibody levels were found to be positive after two months. This article presents a case of paediatric solid organ transplantation patient who received a measles-mumps-rubella vaccination while receiving immunosuppressive everolimus therapy.

Özet

İnfeksiyon riskinin artmış olduğu pediatrik transplantasyon hastalarında canlı aşıların uygulanması ile ilgili bilgiler sınırlı dır. Yedi yaşında, halen evorolimus kullanmakta olan karaciğer nakli hastası Kızamık-Kabakulak-Kızamıkçık (KKK) aşısı yapılmak amacıyla değerlendirildi. Lenfosit sayısı, immünoglobulin G ve serum everolimus düzeyleri kontrol edildikten sonra KKK aşısı uygulandı. İzlemde yan etki saptanmayan olguda, iki ay sonra bakılan antikor düzeyleri pozitif bulundu. Bu yazıda immüno supresif everolimus tedavisi alırken Kızamık-Kabakulak-Kıza mıkçık aşısı uygulanan bir pediatrik solid organ nakli olgusu sunulmaktadır.

🔖

Cite This Article

Kaçır, A., Büke, Ö., Karabayır, N., Başıbüyük, M., Bilgin, D. D., Öcal, Ö. (2025). MEASLES-MUMPS-RUBELLA VACCINATION IN A PAEDIATRIC TRANSPLANT PATIENT USING EVEROLIMUS. İstanbul Tıp Fakültesi Dergisi, Cilt: 88 Sayı: 1, 80–82. https://doi.org/10.26650/IUITFD.1509646

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Kamei K. Live attenuated vaccines in patients receiving immunosuppressive agents. Pediatr Nephrol 2023;38(12):3889-900. [CrossRef] google scholar
  2. Coppeta L, Ferrari C, Somma G, Giovinazzo V, Buonomo E, Trabucco Aurilio M, et al. Serological Evaluation for Measles among Italian and Foreign Medical Students in a University Hospital in Rome. Vaccines 2023;11(7):1256. [CrossRef] google scholar
  3. Feldman AG, Beaty BL, Curtis D, Juarez-Colunga E, Kempe A. Incidence of Hospitalization for Vaccine-Preventable Infections in Children Following Solid Organ Transplant and Associated Morbidity, Mortality, and Costs. JAMA Pediatr 2019;173(3):260-8. [CrossRef] google scholar
  4. Liu Y, Sun LY, Zhu ZJ, Lin W, Qu W, Zeng ZG. Measles Virus Infection in Pediatric Liver Transplantation Recipients. Transplant Proc 2015;47(9):2715-8. [CrossRef] google scholar
  5. Suresh S, Upton J, Green M, Pham-Huy A, Posfay-Barbe KM, Michaels MG, et al. Live vaccines after pediatric solid organ transplant: Proceedings of a consensus meeting, 2018. Pediatr Transplant 2019;23(7):e13571. [CrossRef] google scholar
  6. Manzia TM, Antonelli B, Carraro A, Conte G, Guglielmo N, Lauterio A, et al. Immunosuppression in adult liver transplant recipients: a 2024 update from the Italian Liver Transplant Working Group. Hepatol Int 2024;18(5):1416-30 [CrossRef] google scholar
  7. Shipkova M, Hesselink DA, Holt DW, Billaud EM, van Gelder T, Kunicki PK, et al. Therapeutic Drug Monitoring of Everolimus: A Consensus Report. Therapeutic Drug Monitoring 2016;38(2):143. [CrossRef] google scholar
  8. Witzke O, Sommerer C, Arns W. Everolimus immunosuppression in kidney transplantation: What is the optimal strategy? Transplant Rev (Orlando) 2016;30(1):3-12. [CrossRef] google scholar
  9. Keskindemirci G, Önal Z, Özbörü Aşkan Ö, Yücel E, Varol S, Hançerli Törün S, et al. Attenuated live vaccine in children with solid organ transplantation on everolimus therapy: Report of two cases. Pediatr Transplant 2023;27(2):e14426. [CrossRef] google scholar
  10. Shinjoh M, Hoshino K, Takahashi T, Nakayama T. Updated data on effective and safe immunizations with live-attenuated vaccines for children after living donor liver transplantation. Vaccine 2015;33(5):701-7. [CrossRef] google scholar
  11. Kawano Y, Suzuki M, Kawada J ichi, Kimura H, Kamei H, Ohnishi Y, et al. Effectiveness and safety of immunization with live-attenuated and inactivated vaccines for pediatric liver transplantation recipients. Vaccine 2015;33(12):1440-5. [CrossRef] google scholar
  12. Hartley C, Thomas T, Smith SK, Karnsakul W. Live-Attenuated Vaccines in Pediatric Solid Organ Transplant. Vaccines 2024;12(4):376. [CrossRef] google scholar